EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models

Susumu Ikenoshita, Kazuya Matsuo, Yasushi Yabuki, Kosuke Kawakubo, Sefan Asamitsu, Karin Hori, Shingo Usuki, Yuki Hirose, Toshikazu Bando, Kimi Araki, Mitsuharu Ueda, Hiroshi Sugiyama and 1 more

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci164792 ↗

At a glance

Journal article in Journal of Clinical Investigation, 2023. Written by Susumu Ikenoshita and 12 co-authors. Institution: Department of Genomic Neurology, Institute of Molecular Embryology and Genetics (IMEG). Major MEDLINE topics: Myotonic Dystrophy, Huntington Disease. Cited 13 times so far (Crossref); 86 references. The full text is freely available (open access, CC BY 4.0). Funded by: Institute of Molecular Embryology and Genetics, Kumamoto University, Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Expansion of CAG and CTG (CWG) triplet repeats causes several inherited neurological diseases. The CWG repeat diseases are thought to involve complex pathogenic mechanisms through expanded CWG repeat-derived RNAs in a noncoding region and polypeptides in a coding region, respectively. However, an effective therapeutic approach has not been established for the CWG repeat diseases. Here, we show that a CWG repeat DNA-targeting compound, cyclic pyrrole-imidazole polyamide (CWG-cPIP), suppressed the pathogenesis of coding and noncoding CWG repeat diseases. CWG-cPIP bound to the hairpin form of mismatched CWG DNA, interfering with transcription elongation by RNA polymerase through a preferential activity toward repeat-expanded DNA. We found that CWG-cPIP selectively inhibited pathogenic mRNA transcripts from expanded CWG repeats, reducing CUG RNA foci and polyglutamine accumulation in cells from patients with myotonic dystrophy type 1 (DM1) and Huntington's disease (HD). Treatment with CWG-cPIP ameliorated behavioral deficits in adeno-associated virus-mediated CWG repeat-expressing mice and in a genetic mouse model of HD, without cytotoxicity or off-target effects. Together, we present a candidate compound that targets expanded CWG repeat DNA independently of its genomic location and reduces both pathogenic RNA and protein levels. CWG-cPIP may be used for the treatment of CWG repeat diseases and improvement of clinical outcomes.

Subjects

MeSH terms (MEDLINE)

Myotonic DystrophyHuntington DiseaseHumansAnimalsMiceRNATrinucleotide Repeat ExpansionNylonsTrinucleotide RepeatsDNAImidazolesInositol PhosphatesProstaglandins E

Author keywords

Genetic diseasesNeuroscienceNoncoding RNAsTherapeuticsTranscription

Substances

RNANylonsDNAImidazolesprostaglandin-inositol cyclic phosphateInositol PhosphatesProstaglandins E

Authors and institutions

  • Department of Genomic Neurology, Institute of Molecular Embryology and Genetics (IMEG).
  • Department of Neurology, Graduate School of Medical Sciences.
  • Graduate School of Pharmaceutical Sciences, and.
  • Liaison Laboratory Research Promotion Center, IMEG, Kumamoto University, Kumamoto, Japan.
  • Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.
  • Institute of Resource Development and Analysis and.

Funding

  • Institute of Molecular Embryology and Genetics, Kumamoto University
  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development

Cite

APA

Ikenoshita, S., Matsuo, K., Yabuki, Y., Kawakubo, K., Asamitsu, S., Hori, K., Usuki, S., Hirose, Y., Bando, T., Araki, K., Ueda, M., Sugiyama, H., & Shioda, N. (2023). A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models. Journal of Clinical Investigation. https://doi.org/10.1172/jci164792

Vancouver

Ikenoshita S, Matsuo K, Yabuki Y, Kawakubo K, Asamitsu S, Hori K, et al. A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models. Journal of Clinical Investigation. 2023. doi:10.1172/jci164792

BibTeX
@article{Ikenoshita2023,
  author = {Ikenoshita, Susumu and Matsuo, Kazuya and Yabuki, Yasushi and Kawakubo, Kosuke and Asamitsu, Sefan and Hori, Karin and Usuki, Shingo and Hirose, Yuki and Bando, Toshikazu and Araki, Kimi and Ueda, Mitsuharu and Sugiyama, Hiroshi and Shioda, Norifumi},
  title = {A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci164792}
}
Start for free →